These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11018189)

  • 1. Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris.
    Kugiyama K; Ota Y; Sugiyama S; Kawano H; Doi H; Soejima H; Miyamoto S; Ogawa H; Takazoe K; Yasue H
    Am J Cardiol; 2000 Oct; 86(7):718-22. PubMed ID: 11018189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.
    Mallat Z; Steg PG; Benessiano J; Tanguy ML; Fox KA; Collet JP; Dabbous OH; Henry P; Carruthers KF; Dauphin A; Arguelles CS; Masliah J; Hugel B; Montalescot G; Freyssinet JM; Asselain B; Tedgui A
    J Am Coll Cardiol; 2005 Oct; 46(7):1249-57. PubMed ID: 16198839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up.
    Hartford M; Wiklund O; Mattsson Hultén L; Perers E; Person A; Herlitz J; Hurt-Camejo E; Karlsson T; Caidahl K
    Int J Cardiol; 2006 Mar; 108(1):55-62. PubMed ID: 16516698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease.
    Kugiyama K; Ota Y; Takazoe K; Moriyama Y; Kawano H; Miyao Y; Sakamoto T; Soejima H; Ogawa H; Doi H; Sugiyama S; Yasue H
    Circulation; 1999 Sep; 100(12):1280-4. PubMed ID: 10491371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study.
    Mallat Z; Benessiano J; Simon T; Ederhy S; Sebella-Arguelles C; Cohen A; Huart V; Wareham NJ; Luben R; Khaw KT; Tedgui A; Boekholdt SM
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1177-83. PubMed ID: 17303774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elevated serum secretory type II phospholipase A2 in patients with coronary heart disease].
    Yu L; Jiang WB; Fu GS; Qin GM; Wang JH; Huang ZQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):812-5. PubMed ID: 17217690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
    Zebrack JS; Anderson JL; Maycock CA; Horne BD; Bair TL; Muhlestein JB;
    Am J Cardiol; 2002 Jan; 89(2):145-9. PubMed ID: 11792332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Haverkate F; Thompson SG; Pyke SD; Gallimore JR; Pepys MB
    Lancet; 1997 Feb; 349(9050):462-6. PubMed ID: 9040576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma platelet-derived growth factor levels in coronary circulation in unstable angina pectoris.
    Ogawa H; Yasue H; Misumi I; Masuda T; Okumura K; Bannai S; Takanashi N; Tsukada Y
    Am J Cardiol; 1992 Feb; 69(5):453-6. PubMed ID: 1736605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels and vascular effects of endothelin and big endothelin in patients with stable and unstable angina pectoris undergoing coronary bypass grafting.
    Lockowandt U; Bjessmo S; Ivert T; Franco-Cereceda A
    Eur J Cardiothorac Surg; 2002 Feb; 21(2):218-23. PubMed ID: 11825727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
    Boekholdt SM; Keller TT; Wareham NJ; Luben R; Bingham SA; Day NE; Sandhu MS; Jukema JW; Kastelein JJ; Hack CE; Khaw KT
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):839-46. PubMed ID: 15692105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.
    Liuzzo G; Biasucci LM; Gallimore JR; Grillo RL; Rebuzzi AG; Pepys MB; Maseri A
    N Engl J Med; 1994 Aug; 331(7):417-24. PubMed ID: 7880233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in plasma levels of secretory type II phospholipase A(2) in patients with coronary spastic angina.
    Kugiyama K; Ota Y; Kawano H; Soejima H; Ogawa H; Sugiyama S; Doi H; Yasue H
    Cardiovasc Res; 2000 Jul; 47(1):159-65. PubMed ID: 10869542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction.
    Xin H; Chen ZY; Lv XB; Liu S; Lian ZX; Cai SL
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):999-1004. PubMed ID: 23661511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes.
    Bayes-Genis A; Conover CA; Overgaard MT; Bailey KR; Christiansen M; Holmes DR; Virmani R; Oxvig C; Schwartz RS
    N Engl J Med; 2001 Oct; 345(14):1022-9. PubMed ID: 11586954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels and values of inflammatory markers in patients with angina pectoris.
    Yip HK; Wu CJ; Hang CL; Chang HW; Yang CH; Hsieh YK; Fang CY; Fu M; Yeh KH; Chen MC
    Int Heart J; 2005 Jul; 46(4):571-81. PubMed ID: 16157948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL.
    Korotaeva AA; Samoilova EV; Kaminny AI; Pirkova AA; Resink TJ; Erne P; Prokazova NV; Tkachuk VA; Chazov EI
    Mol Cell Biochem; 2005 Feb; 270(1-2):107-13. PubMed ID: 15792359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endothelin and big endothelin in coronary heart disease and acute coronary syndromes].
    Borries M; Heins M; Fischer Y; Stiegler H; Schoebel FC; Reinauer H; Strauer BE; Leschke M
    Z Kardiol; 1996 Oct; 85(10):761-7. PubMed ID: 9036701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated level of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile.
    Li JJ; Jiang H; Huang CX; Fang CH; Tang QZ; Xia H; Liu J; Li GS
    Angiology; 2002; 53(3):265-72. PubMed ID: 12025913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.